Bob Herman Sep 22
SaveSave story

AbbVie believes political risks of drug pricing are "waning"

AbbVie doesn't foresee drug pricing regulation. Photo: Nam Y. Huh / AP

President Trump and left-leaning lawmakers have excoriated pharmaceutical companies for the rising prices of prescription drugs. But top executives of drug giant AbbVie, including CEO Richard Gonzalez, think the outrage is fading and won't lead to any large-scale changes, according to a meeting AbbVie held with pharmaceutical analysts from investment bank Leerink Partners.

Key quote, from the Leerink report: "AbbVie believes that the intensity of the drug pricing debates and political risks is waning, and ... the company now sees little risk of significant changes in drug price regulation in the U.S., at least for the foreseeable future."

The bottom line: Trump's attacks on the drug industry once again look empty. Lawmakers, the FDA and the drug industry have tossed around some ideas that tinker with drug competition, but anything involving price controls has been a nonstarter for nearly everyone in Congress.

But wait, there's more: AbbVie, which makes the top-selling drug Humira, had committed to limiting price increases to below 10% no more than once a year. But AbbVie executives told Leerink analysts they created that policy due to "the political landscape surrounding drug pricing," and that it could "revert to more than one price increase per year and to double-digit increases in 2018 and beyond."

Khorri Atkinson 4 hours ago
SaveSave story

Court strikes down motion to block new Pennsylvania congressional map

A Federal court on Monday refused to block new congressional district map in Pennsylvania, a significant blow to national and state Republicans who sought to halt it.

This is a developing story. Please check back for updates.

Zachary Basu 4 hours ago
SaveSave story

Pedestrian killed by self-driving Uber in Arizona

Uber autonomous
An Uber driverless Ford Fusion drives down Smallman Street on September, 22, 2016 in Pittsburgh, Pennsylvania. Photo: Jeff Swensen / Getty Images

A pedestrian was struck and killed by a self-driving Uber in Tempe, Arizona, early Monday morning, according to ABC15. Tempe police said that the vehicle was in autonomous mode, though a safety driver was behind the wheel at the time of the crash.

Why it matters: The New York Times notes that this could be the first pedestrian ever killed by a self-driving vehicle. Uber says it's closely following its incident response process, though it declined to share more details about what that entails. The company has also paused its self-driving cars in all locations (Pittsburgh, Tempe, San Francisco and Toronto).